Association of C-reactive protein with efficacy of avelumab plus axitinib in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101

BACKGROUND: C-reactive protein (CRP) is an important prognostic and predictive factor in advanced renal cell carcinoma (aRCC). We report the association of CRP levels at baseline and early after treatment with efficacy of avelumab plus axitinib or sunitinib from the phase III JAVELIN Renal 101 trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Y., Larkin, J., Venugopal, B., Haanen, J., Kanayama, H., Eto, M., Grimm, M.-O., Fujii, Y., Umeyama, Y., Huang, B., Mariani, M., di Pietro, A., Choueiri, T.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588905/
https://www.ncbi.nlm.nih.gov/pubmed/36037566
http://dx.doi.org/10.1016/j.esmoop.2022.100564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588905/
https://www.ncbi.nlm.nih.gov/pubmed/36037566
http://dx.doi.org/10.1016/j.esmoop.2022.100564

Ejemplares similares